ClinicalTrialsFinder

Bronchiolitis Obliterans Syndrome Clinical Trials in Stanford, California

1 recruitingStanford, California

Showing 1–1 of 1 trials

Recruiting
Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled6 locationsNCT05922761